{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": [], "KeywordList": [["fetal hemoglobin", "medicinal plants", "psoralens", "rapamycin", "red wine", "resveratrol", "\u03b2-thalassemia"]], "GeneralNote": [], "PMID": "18955291", "DateCompleted": {"Year": "2011", "Month": "07", "Day": "14"}, "DateRevised": {"Year": "2022", "Month": "01", "Day": "29"}, "Article": {"ArticleDate": [{"Year": "2007", "Month": "12", "Day": "11"}], "Language": ["eng"], "ELocationID": ["10.1093/ecam/nem139"], "Journal": {"ISSN": "1741-427X", "JournalIssue": {"Volume": "6", "Issue": "2", "PubDate": {"Year": "2009", "Month": "Jun"}}, "Title": "Evidence-based complementary and alternative medicine : eCAM", "ISOAbbreviation": "Evid Based Complement Alternat Med"}, "ArticleTitle": "Fetal Hemoglobin Inducers from the Natural World: A Novel Approach for Identification of Drugs for the Treatment of {beta}-Thalassemia and Sickle-Cell Anemia.", "Pagination": {"StartPage": "141", "EndPage": "151", "MedlinePgn": "141-51"}, "Abstract": {"AbstractText": ["The objective of this review is to present examples of lead compounds identified from biological material (fungi, plant extracts and agro-industry material) and of possible interest in the field of a pharmacological approach to the therapy of beta-thalassemia using molecules able to stimulate production of fetal hemoglobin (HbF) in adults. Concerning the employment of HbF inducers as potential drugs for pharmacological treatment of beta-thalassemia, the following conclusions can be reached: (i) this therapeutic approach is reasonable, on the basis of the clinical parameters exhibited by hereditary persistence of fetal hemoglobin patients, (ii) clinical trials (even if still limited) employing HbF inducers were effective in ameliorating the symptoms of beta-thalassemia patients, (iii) good correlation of in vivo and in vitro results of HbF synthesis and gamma-globin mRNA accumulation indicates that in vitro testing might be predictive of in vivo responses and (iv) combined use of different inducers might be useful to maximize HbF, both in vitro and in vivo. In this review, we present three examples of HbF inducers from the natural world: (i) angelicin and linear psoralens, contained in plant extracts from Angelica arcangelica and Aegle marmelos, (ii) resveratrol, a polyphenol found in grapes and several plant extracts and (iii) rapamycin, isolated from Streptomyces hygroscopicus."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "GenTech-for-Thal, Laboratory for the Development of Pharmacological and Pharmacogenomic Therapy of Thalassaemia, Biotechnology Centre, Ferrara, Italy. gam@unife.it."}], "Identifier": [], "LastName": "Bianchi", "ForeName": "Nicoletta", "Initials": "N"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Zuccato", "ForeName": "Cristina", "Initials": "C"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Lampronti", "ForeName": "Ilaria", "Initials": "I"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Borgatti", "ForeName": "Monica", "Initials": "M"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Gambari", "ForeName": "Roberto", "Initials": "R"}], "GrantList": [{"GrantID": "GGP07257", "Acronym": "TI_", "Agency": "Telethon", "Country": "Italy"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Evid Based Complement Alternat Med", "NlmUniqueID": "101215021", "ISSNLinking": "1741-427X"}}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Steinberg MH, Forget BG, Higgs DR, Nagel RL. Disorders of Hemoglobin: Genetics, Pathophysiology and Clinical Management. Cambridge, UK: Cambridge University Press; 2001."}, {"Citation": "Thein SL. Genetic insights into the clinical diversity of beta thalassaemia. Br J Haematol. 2004;124:264\u201374.", "ArticleIdList": ["14717773"]}, {"Citation": "Old JM. Screening and genetic diagnosis of haemoglobin disorders. Blood Rev. 2003;17:43\u201353.", "ArticleIdList": ["12490210"]}, {"Citation": "Thein SL. Beta-thalassaemia prototype of a single gene disorder with multiple phenotypes. Int J Hematol. 2002;76:96\u2013104.", "ArticleIdList": ["12430908"]}, {"Citation": "Fucharoen S, Winichagoon P. Thalassemia and abnormal hemoglobin. Int J Hematol. 2002;76:83\u20139.", "ArticleIdList": ["12430905"]}, {"Citation": "Schrier SL. Pathophysiology of thalassemia. Curr Opin Hematol. 2002;9:123\u20136.", "ArticleIdList": ["11844995"]}, {"Citation": "Wonke B. Clinical management of beta-thalassemia major. Semin Hematol. 2001;38:350\u20139.", "ArticleIdList": ["11605170"]}, {"Citation": "Hardison RC, Chui DH, Giardine B, Riemer C, Patrinos GP, Anagnou N, et al. HbVar: A relational database of human hemoglobin variants and thalassemia mutations at the globin gene server HbVar. Hum Mutat. 2002;19:225\u201333.", "ArticleIdList": ["11857738"]}, {"Citation": "Patrinos GP, Giardine B, Riemer C, Miller W, Chui DH, Anagnou NP, et al. Improvements in the HbVar database of human hemoglobin variants and thalassemia mutations for population and sequence variation studies. Nucleic Acids Res. 2004;1:537\u201341.", "ArticleIdList": ["PMC308741", "14681476"]}, {"Citation": "Kutlar A. Sickle cell disease: a multigenic perspective of a single gene disorder. Hemoglobin. 2007;31:209\u201324.", "ArticleIdList": ["17486504"]}, {"Citation": "Frenette PS, Atweh GF. Sickle cell disease: old discoveries, new concepts, and future promise. J Clin Invest. 2007;117:850\u20138.", "ArticleIdList": ["PMC1838946", "17404610"]}, {"Citation": "Osti F, Corradini FG, Hanau S, Matteuzzi M, Gambari R. Human leukemia K562 cells: induction to erythroid differentiation by guanine, guanosine and guanine nucleotides. Haematologica. 1997;82:395\u2013401.", "ArticleIdList": ["9299849"]}, {"Citation": "Lampronti I, Bianchi N, Zuccato C, Medici A, Bergamini P, Gambari R. Effects on erythroid differentiation of platinum(II) complexes of synthetic bile acid derivatives. Bioorg Med Chem. 2006;14:5204\u201310.", "ArticleIdList": ["16709458"]}, {"Citation": "Olivieri NF. Reactivation of fetal hemoglobin in patients with beta-thalassemia. Semin Hematol. 1996;33:24\u201342.", "ArticleIdList": ["8714583"]}, {"Citation": "Blau CA, Stamatoyannopoulos G. Hemoglobin switching and its clinical implications. Curr Opin Hematol. 1994;1:136\u201342.", "ArticleIdList": ["9371272"]}, {"Citation": "Forget BG. Molecular basis of hereditary persistence of fetal hemoglobin. Ann N Y Acad Sci. 1998;850:38\u201344.", "ArticleIdList": ["9668525"]}, {"Citation": "Bhardwaj U, McCabe ER. Multiplex-PCR assay for the deletions causing hereditary persistence of fetal hemoglobin. Mol Diagn. 2005;9:151\u20136.", "ArticleIdList": ["16271016"]}, {"Citation": "Liu LR, Du ZW, Zhao HL, Liu XL, Huang XD, Shen J, et al. T to C substitution at- 175 or-173 of the gamma-globin promoter affects GATA-1 and Oct-1 binding in vitro differently but can independently reproduce the hereditary persistence of fetal hemoglobin phenotype in transgenic mice. J Biol Chem. 2005;280:7452\u20139.", "ArticleIdList": ["15613485"]}, {"Citation": "Garner C, Dew TK, Sherwood R, Rees D, Thein SL. Heterocellular hereditary persistence of fetal haemoglobin affects the haematological parameters of beta-thalassaemia trait. Br J Haematol. 2003;123:353\u20138.", "ArticleIdList": ["14531920"]}, {"Citation": "Lal A, Vichinsky E. The role of fetal hemoglobin-enhancing agents in thalassemia. Semin Hematol. 2004;41:17\u201322.", "ArticleIdList": ["15534853"]}, {"Citation": "Rodgers GP, Dover GJ, Uyesaka N, Noguchi CT, Schechter AN, Nienhuis AW. Augmentation by erythropoietin of the fetal-hemoglobin response to hydroxyurea in sickle cell disease. N Engl J Med. 1993;328:73\u201380.", "ArticleIdList": ["7677965"]}, {"Citation": "Rodgers GP, Rachmilewitz EA. Novel treatment options in the severe beta-globin disorders. Br J Haematol. 1995;91:263\u20138.", "ArticleIdList": ["8547060"]}, {"Citation": "Steinberg MH, Lu LZ, Barton FB, Terrin ML, Charache S, Dover GJ. Fetal hemoglobin in sickle cell anemia: determinants of response to hydroxyurea. Multicenter Study of Hydroxyurea. Blood. 1997;89:1078\u201388.", "ArticleIdList": ["9028341"]}, {"Citation": "Olivieri NF, Rees DC, Ginder GD, Thein SL, Waye JS, Chang L, et al. Elimination of transfusions through induction of fetal hemoglobin synthesis in Cooley's anemia. Ann N Y Acad Sci. 1998;850:100\u20139.", "ArticleIdList": ["9668532"]}, {"Citation": "Swank RA, Stomatoyannopoulos G. Fetal gene reactivation. Curr Opin Genet Dev. 1998;8:366\u201370.", "ArticleIdList": ["9691002"]}, {"Citation": "Cao H. Pharmacological induction of fetal hemoglobin synthesis using histone deacetylase inhibitors. Hematology. 2004;9:223\u201333.", "ArticleIdList": ["15204104"]}, {"Citation": "Lo L, Singer ST. Thalassemia: current approach to an old disease. Pediatr Clin North Am. 2002;49:1165\u201391.", "ArticleIdList": ["12580361"]}, {"Citation": "Atweh GF, Loukopoulos D. Pharmacological induction of fetal hemoglobin in sickle cell disease and beta-thalassemia. Semin Hematol. 2001;38:367\u201373.", "ArticleIdList": ["11605172"]}, {"Citation": "Olivieri NF, Weatherall DJ. The therapeutic reactivation of fetal haemoglobin. Hum Mol Genet. 1998;7:1655\u20138.", "ArticleIdList": ["9735388"]}, {"Citation": "Yavarian M, Karimi M, Bakker E, Harteveld CL, Giordano PC. Response to hydroxyurea treatment in Iranian transfusion-dependent beta-thalassemia patients. Haematologica. 2004;89:1172\u20138.", "ArticleIdList": ["15477200"]}, {"Citation": "Bradai M, Abad MT, Pissard S, Lamraoui F, Skopinski L, de Montalembert M. Hydroxyurea can eliminate transfusion requirements in children with severe beta-thalassemia. Blood. 2003;102:1529\u201330.", "ArticleIdList": ["12702505"]}, {"Citation": "Alebouyeh M, Moussavi F, Haddad-Deylami H, Vossough P. Hydroxyurea in the treatment of major beta-thalassemia and importance of genetic screening. Ann Hematol. 2004;83:430\u20133.", "ArticleIdList": ["14722738"]}, {"Citation": "Dixit A, Chatterjee TC, Mishra P, Choudhry DR, Mahapatra M, Tyagi S, et al. Hydroxyurea in thalassemia intermedia-a promising therapy. Ann Hematol. 2005;84:441\u20136.", "ArticleIdList": ["15838670"]}, {"Citation": "Karimi M, Darzi H, Yavarian M. Hematologic and clinical responses of thalassemia intermedia patients to hydroxyurea during 6 years of therapy in Iran. J Pediatr Hematol Oncol. 2005;27:380\u20135.", "ArticleIdList": ["16012328"]}, {"Citation": "Singer ST, Kuypers FA, Olivieri NF, Weatherall DJ, Mignacca R, Coates TD, et al. Fetal haemoglobin augmentation in E/beta(0) thalassaemia: clinical and haematological outcome. Br J Haematol. 2005;131:378\u201388.", "ArticleIdList": ["16225658"]}, {"Citation": "Watanapokasin R, Sanmund D, Winichagoon P, Muta K, Fucharoen S. Hydroxyurea responses and fetal hemoglobin induction in beta-thalassemia/HbE patients\u2019 peripheral blood erythroid cell culture. Ann Hematol. 2006;85:164\u20139.", "ArticleIdList": ["16389564"]}, {"Citation": "Watanapokasin Y, Chuncharunee S, Sanmund D, Kongnium W, Winichagoon P, Rodgers GP, et al. In vivo and in vitro studies of fetal hemoglobin induction by hydroxyurea in beta-thalassemia/hemoglobin E patients. Exp Hematol. 2005;33:1486\u201392.", "ArticleIdList": ["16338491"]}, {"Citation": "Marianna P, Kollia P, Akel S, Papassotiriou Y, Stamoulakatou A, Loukopoulos D. Valproic acid, trichostatin and their combination with hemin preferentially enhance gamma-globin gene expression in human erythroid liquid cultures. Haematologica. 2001;86:700\u20135.", "ArticleIdList": ["11454524"]}, {"Citation": "Singer ST, Kuypers FA, Olivieri NF, Weatherall DJ, Mignacca R, Coates TD, et al. Single and combination drug therapy for fetal hemoglobin augmentation in hemoglobin E-{beta}0-Thalassemia: considerations for treatment. Ann N Y Acad Sci. 2005;1054:250\u20136.", "ArticleIdList": ["16339672"]}, {"Citation": "Fathallah H, Atweh GF. DNA hypomethylation therapy for hemoglobin disorders: molecular mechanisms and clinical applications. Blood Rev. 2006;20:227\u201334.", "ArticleIdList": ["16513230"]}, {"Citation": "DeSimone J. The evolving role of DNA demethylating agents in the treatment of sickle cell disease and thalassemia. Semin Hematol. 2004;41:1\u20133.", "ArticleIdList": ["15799099"]}, {"Citation": "Perrine SP, Ginder GD, Faller DV, Dover GH, Ikuta T, Witkowska HE, et al. A short-term trial of butyrate to stimulate fetal-globin-gene expression in the beta-globin disorders. N Engl J Med. 1993;328:81\u20136.", "ArticleIdList": ["7677966"]}, {"Citation": "Skarpidi E, Vassilopoulos G, Li Q, Stamatoyannopoulos G. Novel in vitro assay for the detection of pharmacologic inducers of fetal hemoglobin. Blood. 2000;96:321\u20136.", "ArticleIdList": ["10891468"]}, {"Citation": "Vadolas J, Wardan H, Orford M, Williamson R, Ioannou PA. Cellular genomic reporter assays for screening and evaluation of inducers of fetal hemoglobin. Hum Mol Genet. 2004;13:223\u201333.", "ArticleIdList": ["14645208"]}, {"Citation": "Vadolas J, Wardan H, Orford M, Voullaire L, Zaibak F, Williamson R, et al. Development of sensitive fluorescent assays for embryonic and fetal hemoglobin inducers using the human beta-globin locus in erythropoietic cells. Blood. 2002;100:4209\u201316.", "ArticleIdList": ["12393613"]}, {"Citation": "Lozzio CB, Lozzio BB. Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome. Blood. 1975;45:321\u201334.", "ArticleIdList": ["163658"]}, {"Citation": "Rutherford T, Clegg JB, Higgs DR, Jones RW, Thompson J, Weatherall DJ. Embryonic erythroid differentiation in the human leukemic cell line K562. Proc Natl Acad Sci USA. 1981;78:348\u201352.", "ArticleIdList": ["PMC319050", "6264439"]}, {"Citation": "Rutherford TR, Clegg JB, Weatherall DJ. K562 human leukaemic cells synthesise embryonic haemoglobin in response to haemin. Nature. 1979;280:164\u20135.", "ArticleIdList": ["95354"]}, {"Citation": "Bianchi N, Chiarabelli C, Borgatti M, Mischiati C, Fibach E, Gambari R. Accumulation of gamma-globin mRNA and induction of erythroid differentiation after treatment of human leukaemic K562 cells with tallimustine. Br J Haematol. 2001;113:951\u201361.", "ArticleIdList": ["11442489"]}, {"Citation": "Bianchi N, Ongaro F, Chiarabelli C, Gualandi L, Mischiati C, Bergamini P, et al. Induction of erythroid differentiation of human K562 cells by cisplatin analogs. Biochem Pharmacol. 2000;60:31\u201340.", "ArticleIdList": ["10807942"]}, {"Citation": "Bianchi N, Osti F, Rutigliano C, Corradini FG, Borsetti E, Tomassetti M, et al. The DNA-binding drugs mithramycin and chromomycin are powerful inducers of erythroid differentiation of human K562 cells. Br J Haematol. 1999;104:258\u201365.", "ArticleIdList": ["10050705"]}, {"Citation": "Fibach E, Manor D, Oppenheim A, Rachmilewitz EA. Proliferation and maturation of human erythroid progenitors in liquid culture. Blood. 1989;73:100\u20133.", "ArticleIdList": ["2910352"]}, {"Citation": "Fibach E, Kollia P, Schechter AN, Noguchi CT, Rodgers GP. Hemin-induced acceleration of hemoglobin production in immature cultured erythroid cells: preferential enhancement of fetal hemoglobin. Blood. 1995;85:2967\u201374.", "ArticleIdList": ["7537986"]}, {"Citation": "Fibach E, Rachmilewitz EA. Stimulation of erythroid progenitors by high concentrations of erythropoietin results in normoblasts arrested in G2 phase of the cell cycle. Exp Hematol. 1993;21:184\u20138.", "ArticleIdList": ["8417955"]}, {"Citation": "Gambari R, Fibach E. Medicinal chemistry of fetal hemoglobin inducers for treatment of beta-thalassemia. Curr Med Chem. 2007;14:199\u2013212.", "ArticleIdList": ["17266579"]}, {"Citation": "Heinrich M, Gibbons S. Ethnopharmacology in drug discovery: an analysis of its role and potential contribution. J Pharm Pharmacol. 2001;53:425\u201332.", "ArticleIdList": ["11341358"]}, {"Citation": "Saad B, Azaizeh H, Said O. Tradition and perspectives of arab herbal medicine: a review. Evid Based Complement Alternat Med. 2005;2:475\u20139.", "ArticleIdList": ["PMC1297506", "16322804"]}, {"Citation": "Khan MT, Lampronti I, Martello D, Bianchi N, Jabbar S, Choudhuri MS, et al. Identification of pyrogallol as an antiproliferative compound present in extracts from the medicinal plant Emblica officinalis: effects on in vitro cell growth of human tumor cell lines. Int J Oncol. 2002;21:187\u201392.", "ArticleIdList": ["12063567"]}, {"Citation": "Luo JZ, Luo L. American ginseng stimulates insulin production and prevents apoptosis through regulation of uncoupling Protein-2 in cultured beta cells. Evid Based Complement Alternat Med. 2006;3:365\u201372.", "ArticleIdList": ["PMC1513144", "16951721"]}, {"Citation": "Jagetia GC, Rao SK. Evaluation of cytotoxic effects of dichloromethane extract of guduchi (Tinospora cordifolia Miers ex Hook F & THOMS) on cultured HeLa cells. Evid Based Complement Alternat Med. 2006;3:267\u201372.", "ArticleIdList": ["PMC1475936", "16786058"]}, {"Citation": "Lambertini E, Piva R, Khan MT, Lampronti I, Bianchi N, Borgatti M, et al. Effects of extracts from Bangladeshi medicinal plants on in vitro proliferation of human breast cancer cell lines and expression of estrogen receptor alpha gene. Int J Oncol. 2004;24:419\u201323.", "ArticleIdList": ["14719119"]}, {"Citation": "Xie F, Wu CF, Lai WP, Yang XJ, Cheung PY, Yao XS, et al. The osteoprotective effect of Herba epimedii (HEP) extract in vivo and in vitro. Evid Based Complement Alternat Med. 2005;2:353\u201361.", "ArticleIdList": ["PMC1193542", "16136213"]}, {"Citation": "Adams LS, Seeram NP, Hardy ML, Carpenter C, Heber D. Analysis of the interactions of botanical extract combinations against the viability of prostate cancer cell lines. Evid Based Complement Alternat Med. 2006;3:117\u201324.", "ArticleIdList": ["PMC1375246", "16550232"]}, {"Citation": "Lampronti I, Khan MTH, Bianchi N, Ather A, Borgatti M, Vizziello L, et al. Bangladeshi medicinal plant extracts inhibiting molecular interactions between nuclear factors and target DNA sequences mimicking NF-kappaB binding sites. Med Chem. 2005;1:327\u201333.", "ArticleIdList": ["16789890"]}, {"Citation": "Lampronti I, Martello D, Bianchi N, Borgatti M, Lambertini E, Piva R, et al. In vitro antiproliferative effects on human tumor cell lines of extracts from the Bangladeshi medicinal plant Aegle marmelos Correa. Phytomedicine. 2003;10:300\u20138.", "ArticleIdList": ["12809360"]}, {"Citation": "Alder R, Lookinland S, Berry JA, Williams M. A systematic review of the effectiveness of garlic as an anti-hyperlipidemic agent. J Am Acad Nurse Pract. 2003;15:120\u20139.", "ArticleIdList": ["12696542"]}, {"Citation": "Wang HX, Ng TB. Natural products with hypoglycemic, hypotensive, hypocholesterolemic, antiatherosclerotic and antithrombotic activities. Life Sci. 1999;65:2663\u201377.", "ArticleIdList": ["10622276"]}, {"Citation": "Luper S. A review of plants used in the treatment of liver disease: part 1. Altern Med Rev. 1998;3:410\u201321.", "ArticleIdList": ["9855566"]}, {"Citation": "Nakhai LA, Mohammadirad A, Yasa N, Minaie B, Nikfar S, Ghazanfari G, et al. Benefits of Zataria multiflora Boiss in experimental model of mouse inflammatory bowel disease. Evid Based Complement Alternat Med. 2007;4:43\u201350.", "ArticleIdList": ["PMC1810372", "17342240"]}, {"Citation": "Salem ML. Immunomodulatory and therapeutic properties of the Nigella sativa L. seed. Int Immunopharmacol. 2005;5:1749\u201370. Epub 2005 Jul 1. Review.", "ArticleIdList": ["16275613"]}, {"Citation": "Martin KW, Ernst E. Antiviral agents from plants and herbs: a systematic review. Antivir Ther. 2003;8:77\u201390.", "ArticleIdList": ["12741619"]}, {"Citation": "Khan MT, Ather A, Thompson KD, Gambari R. Extracts and molecules from medicinal plants against herpes simplex viruses. Antiviral Res. 2005;67:107\u201319.", "ArticleIdList": ["16040137"]}, {"Citation": "Leite SP, Vieira JR, de Medeiros PL, Leite RM, de Menezes Lima VL, Xavier HS, et al. Antimicrobial Activity of Indigofera suffruticosa. Evid Based Complement Alternat Med. 2006;3:261\u20135.", "ArticleIdList": ["PMC1475935", "16786057"]}, {"Citation": "Iyamu EW, Turner EA, Asakura T. In vitro effects of NIPRISAN (Nix-0699): a naturally occurring, potent antisickling agent. Br J Haematol. 2002;118:337\u201343.", "ArticleIdList": ["12100171"]}, {"Citation": "Wambebe C, Khamofu H, Momoh JA, Ekpeyong M, Audu BS, Njoku OS, et al. Double-blind, placebo-controlled, randomised cross-over clinical trial of NIPRISAN in patients with sickle cell disorder. Phytomedicine. 2001;8:252\u201361.", "ArticleIdList": ["11515714"]}, {"Citation": "Chiarabelli C, Bianchi N, Borgatti M, Prus E, Fibach E, Gambari R. Induction of gamma-globin gene expression by tallimustine analogs in human erythroid cells. Haematologica. 2003;88:826\u20137.", "ArticleIdList": ["12857563"]}, {"Citation": "Fibach E, Bianchi N, Borgatti M, Prus E, Gambari R. Mithramycin induces fetal hemoglobin production in normal and thalassemic human erythroid precursor cells. Blood. 2003;102:1276\u201381.", "ArticleIdList": ["12738678"]}, {"Citation": "Lampronti I, Bianchi N, Borgatti M, Fibach E, Prus E, Gambari R. Accumulation of gamma-globin mRNA in human erythroid cells treated with angelicin. Eur J Haematol. 2003;71:189\u201395.", "ArticleIdList": ["12930320"]}, {"Citation": "Dall\u2019Acqua F, Viola G, Vedaldi D. Cellular and molecular target of psoralen. In: Hoorspool WM, Lenci F, editors. CRC Handbook of Organic Photochemistry and Photobiology. Boca Raton, USA: CRC Press; 2004. pp. 1\u201317."}, {"Citation": "Chilin A, Marzano C, Guiotto A, Manzini P, Baccichetti F, Carlassare F, et al. Synthesis and biological activity of (hydroxymethyl)- and (diethylaminomethyl)-benzopsoralens. J Med Chem. 1999;42:2936\u201345.", "ArticleIdList": ["10425103"]}, {"Citation": "Bordin F, Marzano C, Baccichetti F, Carlassare F, Vedaldi D, Falcomer S, et al. Photobiological properties of 1\u2032-thieno-4,6,4\u2032-trimethylangelicin. Photochem Photobiol. 1998;68:157\u201363.", "ArticleIdList": ["9723209"]}, {"Citation": "Conconi MT, Montesi F, Parnigotto PP. Antiproliferative activity and phototoxicity of some methyl derivatives of 5-methoxypsoralen and 5-methoxyangelicin. Pharmacol Toxicol. 1998;82:193\u20138.", "ArticleIdList": ["9584334"]}, {"Citation": "Marzano C, Caffieri S, Fossa P, Bordin F. Activity of 3-carbethoxyangelicin photolysis products. J Photochem Photobiol B. 1997;38:189\u201395.", "ArticleIdList": ["9203380"]}, {"Citation": "Bordin F, Dall\u2019Acqua F, Guiotto A. Angelicins, angular analogs of psoralens: chemistry, photochemical, photobiological and phototherapeutic properties. Pharmacol Ther. 1991;52:331\u201363.", "ArticleIdList": ["1820581"]}, {"Citation": "Guiotto A, Rodighiero P, Manzini P, Pastorini G, Bordin F, Baccichetti F, et al. 6-Methylangelicins: a new series of potential photochemotherapeutic agents for the treatment of psoriasis. J Med Chem. 1984;27:959\u201367.", "ArticleIdList": ["6540313"]}, {"Citation": "Komura J, Ikehata H, Hosoi Y, Riggs AD, Ono T. Mapping psoralen cross-links at the nucleotide level in mammalian cells: suppression of cross-linking at transcription factor- or nucleosome-binding sites. Biochemistry. 2001;40:4096\u2013105.", "ArticleIdList": ["11300790"]}, {"Citation": "Mosti L, Lo Presti E, Menozzi G, Marzano C, Baccichetti F, Falcone G, et al. Synthesis of angelicin heteroanalogues: preliminary photobiological and pharmacological studies. Farmaco. 1998;53:602\u201310.", "ArticleIdList": ["10081825"]}, {"Citation": "Curini M, Cravotto G, Epifano F, Giannone G. Chemistry and biological activity of natural and synthetic prenyloxycoumarins. Curr Med Chem. 2006;13:199\u2013222.", "ArticleIdList": ["16472213"]}, {"Citation": "Santana L, Uriarte E, Roleira F, Milhazes N, Borges F. Furocoumarins in medicinal chemistry. Synthesis, natural occurrence and biological activity. Curr Med Chem. 2004;11:3239\u201361.", "ArticleIdList": ["15579011"]}, {"Citation": "Okamoto T, Kobayashi T, Yoshida S. Chemical aspects of coumarin compounds for the prevention of hepatocellular carcinomas. Curr Med Chem Anticancer Agents. 2005;5:47\u201351.", "ArticleIdList": ["15720260"]}, {"Citation": "Scheinfeld N, Deleo V. A review of studies that have utilized different combinations of psoralen and ultraviolet B phototherapy and ultraviolet A phototherapy. Dermatol Online J. 2003;9:7.", "ArticleIdList": ["14996380"]}, {"Citation": "Khurshid K, Haroon TS, Hussain I, Pal SS, Jahangir M, Zaman T. Psoralen-ultraviolet A therapy vs. psoralen-ultraviolet B therapy in the treatment of plaque-type psoriasis: our experience with Fitzpatrick skin type IV. Int J Dermatol. 2000;39:865\u20137.", "ArticleIdList": ["11123453"]}, {"Citation": "de Berker DA, Sakuntabhai A, Diffey BL, Matthews JN, Farr PM. Comparison of psoralen-UVB and psoralen-UVA photochemotherapy in the treatment of psoriasis. J Am Acad Dermatol. 1997;36:577\u201381.", "ArticleIdList": ["9092744"]}, {"Citation": "Morison WL. Combination of methoxsalen and ultraviolet B (UVB) versus UVB radiation alone in treatment of psoriasis: a bilateral comparison study. Photodermatol Photoimmunol Photomed. 1995;11:6\u20138.", "ArticleIdList": ["7654566"]}, {"Citation": "Honigsmann H. Phototherapy for psoriasis. Clin Exp Dermatol. 2001;26:343\u201350.", "ArticleIdList": ["11422187"]}, {"Citation": "Abel EA. Phototherapy: UVB and PUVA. Cutis. 1999;64:339\u201342.", "ArticleIdList": ["10582160"]}, {"Citation": "McNeely W, Goa KL. 5-Methoxypsoralen. A review of its effects in psoriasis and vitiligo. Drugs. 1998;56:667\u201390.", "ArticleIdList": ["9806110"]}, {"Citation": "McGinnis KS, Shapiro M, Vittorio CC, Rook AH, Junkins-Hopkins JM. Psoralen plus long-wave UV-A (PUVA) and bexarotene therapy: an effective and synergistic combined adjunct to therapy for patients with advanced cutaneous T-cell lymphoma. Arch Dermatol. 2003;139:771\u20135.", "ArticleIdList": ["12810509"]}, {"Citation": "Zarebska Z, Waszkowska E, Caffieri S, Dall\u2019Acqua F. PUVA (psoralen+UVA) photochemotherapy: processes triggered in the cells. Farmaco. 2000;55:515\u201320.", "ArticleIdList": ["11132728"]}, {"Citation": "Bisagni E. Synthesis of psoralens and analogues. J Photochem Photobiol B. 1992;14:23\u201346.", "ArticleIdList": ["1432382"]}, {"Citation": "Rodrigue CM, Arous N, Bachir D, Smith-Ravin J, Romeo PH, Galacteros F, et al. Resveratrol, a natural dietary phytoalexin, possesses similar properties to hydroxyurea towards erythroid differentiation. Br J Haematol. 2001;113:500\u20137.", "ArticleIdList": ["11380423"]}, {"Citation": "Paul B, Masih I, Deopujari J, Charpentier C. Occurrence of resveratrol and pterostilbene in age-old darakchasava, an ayurvedic medicine from India. J Ethnopharmacol. 1999;68:71\u20136.", "ArticleIdList": ["10624864"]}, {"Citation": "Hain R, Bieseler B, Kindl H, Schroder G, Stocker R. Expression of a stilbene synthase gene in Nicotiana tabacum results in synthesis of the phytoalexin resveratrol. Plant Mol Biol. 1990;15:325\u201335.", "ArticleIdList": ["2103451"]}, {"Citation": "Jeandet P, Bessis R, Gautheron B. The production of resveratrol (3,5,4-trihydroxystilbene) by grape berries in different developmental stages. Am J Enol and Vitic. 1991;42:41\u20136."}, {"Citation": "Fontecave M, Lepoivre M, Elleingand E, Gerez C, Guittet O. Resveratrol, a remarkable inhibitor of ribonucleotide reductase. FEBS Letters. 1998;421:277\u20139.", "ArticleIdList": ["9468322"]}, {"Citation": "Frankel EN, Waterhouse AL, Kinsella JE. Inhibition of human LDL oxidation by resveratrol. Lancet. 1993;341:1103\u20134.", "ArticleIdList": ["8097009"]}, {"Citation": "Ferrero ME, Bertelli AE, Fulgenti A, Pellegatta F, Corsi MM, Bonfrate M, et al. Activity in vitro of resveratrol on granulocyte and monocyte adhesion to endothelium. Am J Clin Nutrition. 1998;68:1208\u201314.", "ArticleIdList": ["9846848"]}, {"Citation": "Carbo N, Costelli P, Baccino FM, Lopez-Soriano FJ, Argiles JM. Resveratrol, a natural product present in wine, decreases tumour growth in a rat tumour model. Biochem Biophys Res Commun. 1999;254:739\u201343.", "ArticleIdList": ["9920811"]}, {"Citation": "Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CW, et al. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science. 1997;275:218\u201320.", "ArticleIdList": ["8985016"]}, {"Citation": "Mgbonyebi OP, Russo J, Russo IH. Antiproliferative effect of synthetic resveratrol on human breast epithelial cells. Int J Oncol. 1998;12:865\u20139.", "ArticleIdList": ["9499448"]}, {"Citation": "Cl\u00e8ment MV, Hirpara JL, Chawdhury SH, Pervaiz S. Chemopreventive agent resveratrol, a natural product derived from grapes, triggers CD95 signaling-dependent apoptosis in human tumor cells. Blood. 1998;92:996\u20131002.", "ArticleIdList": ["9680369"]}, {"Citation": "Sehgal SN. Sirolimus: its discovery, biological properties, and mechanism of action. Transplant Proc. 2003;35:S7\u201314.", "ArticleIdList": ["12742462"]}, {"Citation": "Gummert JF, Ikonen T, Morris RE. Newer immunosuppressive drugs: a review. J Am Soc Nephrol. 1999;10:1366\u201380.", "ArticleIdList": ["10361877"]}, {"Citation": "Mischiati C, Sereni A, Lampronti I, Bianchi N, Borgatti M, Prus E, et al. Rapamycin-mediated induction of gamma-globin mRNA accumulation in human erythroid cells. Br J Haematol. 2004;126:612\u201321.", "ArticleIdList": ["15287957"]}, {"Citation": "Saunders RN, Metcalfe MS, Nicholson ML. Rapamycin in transplantation: a review of the evidence. Kidney Internat. 2001;59:3\u201316.", "ArticleIdList": ["11135052"]}, {"Citation": "Fibach E, Bianchi N, Borgatti M, Zuccato C, Finotti A, Lampronti I, et al. Effects of rapamycin on accumulation of \u03b1-,\u03b2- and \u03b3-globin mRNAs in erythroid precursor cells from \u03b2-thalassaemia patients. Eur J Haematol. 2006;77:437\u201341.", "ArticleIdList": ["16939628"]}, {"Citation": "Zuccato C, Bianchi N, Borgatti M, Lampronti I, Massei F, Favre C, et al. Everolimus is a potent inducer of erythroid differentiation and gamma-globin gene expression in human erythroid cells. Acta Haematol. 2007;117:168\u201376.", "ArticleIdList": ["17148936"]}, {"Citation": "Sadelain M, Boulad F, Galanello R, Giardina P, Locatelli F, Maggio A, et al. Therapeutic options for patients with severe \u03b2-thalassemia: the need for globin gene therapy. Hum Gene Ther. 2007;18:1\u20139.", "ArticleIdList": ["17173507"]}, {"Citation": "Quek L, Thein SL. Molecular therapies in beta-thalassaemia. Br J Haematol. 2007;136:353\u201365.", "ArticleIdList": ["17129232"]}, {"Citation": "Gaziev J, Sodani P, Polchi P, Andreani M, Lucarelli G. Bone marrow transplantation in adults with thalassemia: treatment and long-term follow-up. Ann N Y Acad Sci. 2005;1054:196\u2013205.", "ArticleIdList": ["16339666"]}, {"Citation": "Caocci G, Pisu S, Argiolu F, Giardini C, Locatelli F, Vacca A, et al. Decision-making in adult thalassemia patients undergoing unrelated bone marrow transplantation: quality of life, communication and ethical issues. Bone Marrow Transplant. 2006;37:165\u20139.", "ArticleIdList": ["16299541"]}]}], "History": [{"Year": "2008", "Month": "10", "Day": "29", "Hour": "9", "Minute": "0"}, {"Year": "2008", "Month": "10", "Day": "29", "Hour": "9", "Minute": "1"}, {"Year": "2008", "Month": "10", "Day": "29", "Hour": "9", "Minute": "0"}, {"Year": "2007", "Month": "12", "Day": "11"}], "PublicationStatus": "ppublish", "ArticleIdList": ["18955291", "PMC2686630", "10.1093/ecam/nem139", "nem139"]}}], "PubmedBookArticle": []}